The kappa opioid agonist GR89 696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy

Pain

Volumn 79, Issue 2-3, 1999, Pages 255-264

  Eliav, Eli ^a   Herzberg, Uri ^b   Caudle, Robert M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Allodynia; Analgesia; Hyperalgesia; Opioids

Indexed keywords

4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE;

ALLODYNIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NERVE INJURY; NEURITIS; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; COLD; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; MALE; NEURITIS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; PIPERAZINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SCIATIC NERVE; SKIN;

EID: 0033051209     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00177-8     Document Type: Article

References (32)

1. Andersen O.K., Felsby S., Nicolaisen L., Bjerring P., Jensen T.S., Arendt-Nielsen L. The effect of ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin: a double-blind, placebo-controlled, human experimental study. Pain. 66:1996;51-62.
2. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Chaplan S.R., Malmberg A.B., Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J. Pharmacol. Exp. Ther. 280:1997;829-838.
4. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in rat model of neuropathic pain. Pain. 59:1994;369-376.
5. 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J. Neurosci. 14:1994;5580-5589.
6. Caudle R.M., Mannes A.J., Iadarola M.J. GR89 696 is a kappa-2 agonist and a kappa-1 antagonist in the guinea pig hippocampus. J. Pharmacol. Exp. Ther. 283:1997;1342-1349.
7. Desmeules J.A., Kayser V., Guilbaud G. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain. 53:1993;277-285.
8. Dickenson, A.H., NMDA receptor antagonists as analgesics. In: H.L. Fields and J.C. Liebeskind (Eds.), Progress in Pain Research and Management, Vol. 1, IASP Press, Seattle, WA, 1994, pp. 173-187.
9. Eliav, E. and Bennett, G.J., An Experimental Neuritis of the Rat Sciatic Nerve that Produces Allodynia and Hyperalgesia at the Hind Paw. 8th World Congress on Pain, Vancouver, British Columbia, Canada, 1996.
10. Eliav E., Ruda M.A., Bennett G.I. An experimental neuritis of the rat sciatic nerve produces ipsilateral hindpaw allodynia and hyperalgesia. Soc. Neurosci. Abstr. 22:1996;865.
11. Guirimand F., Strimbu-Gozariu M., Willer J.C., Le Bars D.J. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAMGO. J. Pharmacol. Exp. Ther. 269:1994;1007-1020.
12. Hargreaves K., Dubner R., Brown F., Floes C., Joris J. A new sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
13. Ho J., Mannes A.J., Dubner R., Caudle R.M. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. J. Pharmacol. Exp. Ther. 281:1997;136-141.
14. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
15. Keita H., Kayser V., Guilbaud G. Antinociceptive effect of a k-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204 448) in a rat model of mononeuropathy. Eur. J. Phamacol. 277:1995;275-280.
16. Lee S.H., Kayser V., Desmeules J., Guilbaud G. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats. Pain. 57:1994;233-240.
17. Lee Y.W., Chaplan S.R., Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 199:1995;111-114.
18. Max M.B., Byas-Smith M.G., Gracely R.H., Bennett G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin. Neuropharmacol. 18:1995;360-368.
19. Mestre K., Pélissier T., Fialip J., Wilcox G., Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J. Pharmacol. Toxicol. Meth. 32:1994;197-200.
20. Naylor A., Judd D.B., Lloyd J.E., Scopes D.I.C., Hayes A.G., Birch P.J. A potent new class of k-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines. J. Med. Chem. 36:1993;2075-2083.
21. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., Jensen T.S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain. 67:1996;69-77.
22. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
23. Ossipov M.H., Lopez Y., Bian D., Nichols M.L., Porreca F. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury. Anesthesiology. 86:1997;196-204.
24. Ren, K., Hylden, J.L.K., Williams, G.M., Ruda, M.A. and Dubner, R., The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation, Pain, 50 (1992a) 331-344.
25. Ren, K., Williams, G.M., Hylden, J.L.K., Ruda, M.A. and Dubner, R., The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats, Eur. J. Pharmacol., 219 (1992b) 235-243.
26. Ren K., Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw. Neurosci. Lett. 163:1993;22-26.
27. Ren K. Wind-up and the NMDA receptor: from animal studies to humans. Pain. 59:1994;157-158.
28. Sang C.N., Gracely R.H., Max M.B., Bennett G.J. Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology. 85:1996;491-496.
29. Tal M., Bennett G.J. Extra-territorial pain in rats with peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an injured nerve. Pain. 57:1994;375-382.
30. Tolle T.R., Berthele A., Laurie D.J., Seeburg P.H., Zieglgansberger W. Cellular and subcellular distribution of NMDA R1 splice variant mRNA in the rat lumbar spinal cord. Eur. J. Neurosci. 7:1995;1235-1244.
31. Watanabe M., Mishina M., Inoue Y. Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J. Comp. Neurol. 345:1994;314-319.
32. Zimmerman, M., Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110.